Welcome to LookChem.com Sign In|Join Free
  • or
BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is a chemical compound characterized by the molecular formula C16H20F2N2O4. It is a derivative of 3-amino-4-(3,4-difluoro-phenyl)-butyric acid, known for its utility in pharmaceutical research and development. BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is recognized for its role as a building block in the synthesis of a variety of pharmaceuticals and drugs, making it a significant component in the creation of new and potential therapeutic agents. Its structure and properties are of keen interest to scientists and researchers in the field of medicinal chemistry.

270063-54-2

Post Buying Request

270063-54-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

270063-54-2 Usage

Uses

Used in Pharmaceutical Research and Development:
BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is utilized as a key building block in the synthesis of pharmaceuticals and drugs. It is instrumental in the development of new therapeutic agents due to its unique chemical properties and potential to contribute to the efficacy of various medications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is employed as a valuable component for the design and synthesis of novel compounds with potential therapeutic applications. Its structure allows for the exploration of new chemical spaces and the discovery of innovative drug candidates.
Used in Drug Synthesis:
BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is used as a precursor in the synthesis of various drugs, contributing to the development of pharmaceuticals with specific therapeutic targets and mechanisms of action. Its presence in the synthesis process can influence the pharmacokinetics, pharmacodynamics, and overall effectiveness of the resulting drug molecules.
Used in Drug Discovery:
BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID is leveraged in drug discovery processes to identify and optimize potential drug candidates. Its unique structural features can be exploited to design compounds with improved binding affinities, selectivities, and therapeutic indices, thereby enhancing the chances of discovering effective new medicines.

Check Digit Verification of cas no

The CAS Registry Mumber 270063-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,0,0,6 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 270063-54:
(8*2)+(7*7)+(6*0)+(5*0)+(4*6)+(3*3)+(2*5)+(1*4)=112
112 % 10 = 2
So 270063-54-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H19F2NO4/c1-15(2,3)22-14(21)18-10(8-13(19)20)6-9-4-5-11(16)12(17)7-9/h4-5,7,10H,6,8H2,1-3H3,(H,18,21)(H,19,20)/t10-/m0/s1

270063-54-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-(S)-3-amino-4-(3,4-difluorophenyl)butyric acid

1.2 Other means of identification

Product number -
Other names BOC-(S)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:270063-54-2 SDS

270063-54-2Downstream Products

270063-54-2Relevant academic research and scientific papers

Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors

Xu, Jinyou,Ok, Hyun O.,Gonzalez, Edward J.,Colwell Jr., Lawrence F.,Habulihaz, Bahanu,He, Huaibing,Leiting, Barbara,Lyons, Kathryn A.,Marsilio, Frank,Patel, Reshma A.,Wu, Joseph K.,Thornberry, Nancy A.,Weber, Ann E.,Parmee, Emma R.

, p. 4759 - 4762 (2007/10/03)

Modification of in-house screening lead β-aminoacyl proline 8 gave an equipotent thiazolidide 9. Extensive SAR studies on the phenyl ring of 9 led to the discovery of a novel series of potent and selective DP-IV inhibitors. Introduction of a fluorine at the 2-position proved to be crucial for the potency of this series. The 2,5-difluoro (22q) and 2,4,5-trifluoro (22t) analogues were potent inhibitors of DP-IV (IC50 = 270, 119 nM, respectively).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 270063-54-2